280 related articles for article (PubMed ID: 25786395)
1. Inhibitory effects of relaxin on cardiac fibroblast-to-myofibroblast transition: an electrophysiological study.
Squecco R; Sassoli C; Garella R; Chellini F; Idrizaj E; Nistri S; Formigli L; Bani D; Francini F
Exp Physiol; 2015 Jun; 100(6):652-66. PubMed ID: 25786395
[TBL] [Abstract][Full Text] [Related]
2. Relaxin prevents cardiac fibroblast-myofibroblast transition via notch-1-mediated inhibition of TGF-β/Smad3 signaling.
Sassoli C; Chellini F; Pini A; Tani A; Nistri S; Nosi D; Zecchi-Orlandini S; Bani D; Formigli L
PLoS One; 2013; 8(5):e63896. PubMed ID: 23704950
[TBL] [Abstract][Full Text] [Related]
3. Serelaxin inhibits the profibrotic TGF-β1/IL-1β axis by targeting TLR-4 and the NLRP3 inflammasome in cardiac myofibroblasts.
Cáceres FT; Gaspari TA; Samuel CS; Pinar AA
FASEB J; 2019 Dec; 33(12):14717-14733. PubMed ID: 31689135
[TBL] [Abstract][Full Text] [Related]
4. The anti-fibrotic actions of relaxin are mediated through AT
Wang C; Pinar AA; Widdop RE; Hossain MA; Bathgate RAD; Denton KM; Kemp-Harper BK; Samuel CS
FASEB J; 2020 Jun; 34(6):8217-8233. PubMed ID: 32297670
[TBL] [Abstract][Full Text] [Related]
5. Platelet-Rich Plasma Modulates Gap Junction Functionality and Connexin 43 and 26 Expression During TGF-β1-Induced Fibroblast to Myofibroblast Transition: Clues for Counteracting Fibrosis.
Squecco R; Chellini F; Idrizaj E; Tani A; Garella R; Pancani S; Pavan P; Bambi F; Zecchi-Orlandini S; Sassoli C
Cells; 2020 May; 9(5):. PubMed ID: 32408529
[TBL] [Abstract][Full Text] [Related]
6. Low intensity 635 nm diode laser irradiation inhibits fibroblast-myofibroblast transition reducing TRPC1 channel expression/activity: New perspectives for tissue fibrosis treatment.
Sassoli C; Chellini F; Squecco R; Tani A; Idrizaj E; Nosi D; Giannelli M; Zecchi-Orlandini S
Lasers Surg Med; 2016 Mar; 48(3):318-32. PubMed ID: 26660509
[TBL] [Abstract][Full Text] [Related]
7. Platelet-rich plasma affects gap junctional features in myofibroblasts in vitro via vascular endothelial growth factor (VEGF)-A/VEGF receptor.
Sassoli C; Garella R; Chellini F; Tani A; Pavan P; Bambi F; Zecchi-Orlandini S; Squecco R
Exp Physiol; 2022 Feb; 107(2):106-121. PubMed ID: 34935228
[TBL] [Abstract][Full Text] [Related]
8. DIM attenuates TGF-β1-induced myofibroblast differentiation in neonatal rat cardiac fibroblasts.
Li J; Zhang W; Jiao R; Yang Z; Yuan Y; Wu Q; Hu Z; Xiang S; Tang Q
Int J Clin Exp Pathol; 2015; 8(5):5121-8. PubMed ID: 26191207
[TBL] [Abstract][Full Text] [Related]
9. TGF-β
Salvarani N; Maguy A; De Simone SA; Miragoli M; Jousset F; Rohr S
Circ Arrhythm Electrophysiol; 2017 May; 10(5):e004567. PubMed ID: 28500173
[TBL] [Abstract][Full Text] [Related]
10. Featured Article: TGF-β1 dominates extracellular matrix rigidity for inducing differentiation of human cardiac fibroblasts to myofibroblasts.
Cho N; Razipour SE; McCain ML
Exp Biol Med (Maywood); 2018 Apr; 243(7):601-612. PubMed ID: 29504479
[TBL] [Abstract][Full Text] [Related]
11. Investigations into the inhibitory effects of relaxin on renal myofibroblast differentiation.
Samuel CS; Mookerjee I; Halls ML; Summers RJ; Chew E; Bathgate RA; Tregear GW; Hewitson TD
Ann N Y Acad Sci; 2009 Apr; 1160():294-9. PubMed ID: 19416207
[TBL] [Abstract][Full Text] [Related]
12. Fibroblast growth factor-2, but not the adipose tissue-derived stromal cells secretome, inhibits TGF-β1-induced differentiation of human cardiac fibroblasts into myofibroblasts.
Liguori TTA; Liguori GR; Moreira LFP; Harmsen MC
Sci Rep; 2018 Nov; 8(1):16633. PubMed ID: 30413733
[TBL] [Abstract][Full Text] [Related]
13. Deletion of delta-like 1 homologue accelerates fibroblast-myofibroblast differentiation and induces myocardial fibrosis.
Rodriguez P; Sassi Y; Troncone L; Benard L; Ishikawa K; Gordon RE; Lamas S; Laborda J; Hajjar RJ; Lebeche D
Eur Heart J; 2019 Mar; 40(12):967-978. PubMed ID: 29668883
[TBL] [Abstract][Full Text] [Related]
14. Relaxin regulates myofibroblast contractility and protects against lung fibrosis.
Huang X; Gai Y; Yang N; Lu B; Samuel CS; Thannickal VJ; Zhou Y
Am J Pathol; 2011 Dec; 179(6):2751-65. PubMed ID: 21983071
[TBL] [Abstract][Full Text] [Related]
15. Relaxin modulates cardiac fibroblast proliferation, differentiation, and collagen production and reverses cardiac fibrosis in vivo.
Samuel CS; Unemori EN; Mookerjee I; Bathgate RA; Layfield SL; Mak J; Tregear GW; Du XJ
Endocrinology; 2004 Sep; 145(9):4125-33. PubMed ID: 15155573
[TBL] [Abstract][Full Text] [Related]
16. Andrographolide ameliorates bleomycin-induced pulmonary fibrosis by suppressing cell proliferation and myofibroblast differentiation of fibroblasts via the TGF-β1-mediated Smad-dependent and -independent pathways.
Li J; Feng M; Sun R; Li Z; Hu L; Peng G; Xu X; Wang W; Cui F; Yue W; He J; Liu J
Toxicol Lett; 2020 Mar; 321():103-113. PubMed ID: 31706003
[TBL] [Abstract][Full Text] [Related]
17. Inhibition and reversal of a TGF-β1 induced myofibroblast phenotype by adipose tissue-derived paracrine factors.
Higginbotham S; Workman VL; Giblin AV; Green NH; Lambert DW; Hearnden V
Stem Cell Res Ther; 2024 Jun; 15(1):166. PubMed ID: 38867276
[TBL] [Abstract][Full Text] [Related]
18. Endogenous relaxin is a naturally occurring modulator of experimental renal tubulointerstitial fibrosis.
Hewitson TD; Mookerjee I; Masterson R; Zhao C; Tregear GW; Becker GJ; Samuel CS
Endocrinology; 2007 Feb; 148(2):660-9. PubMed ID: 17095590
[TBL] [Abstract][Full Text] [Related]
19. Biomarkers for the identification of cardiac fibroblast and myofibroblast cells.
Tarbit E; Singh I; Peart JN; Rose'Meyer RB
Heart Fail Rev; 2019 Jan; 24(1):1-15. PubMed ID: 29987445
[TBL] [Abstract][Full Text] [Related]
20. Lefty-1 alleviates TGF-β1-induced fibroblast-myofibroblast transdifferentiation in NRK-49F cells.
Zhang L; Zhang J; Xu C; Zhou X; Wang W; Zheng R; Hu W; Wu P
Drug Des Devel Ther; 2015; 9():4669-78. PubMed ID: 26316705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
